These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacotherapy of the ion transport defect in cystic fibrosis. Kunzelmann K, Mall M. Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):857-67. PubMed ID: 11703384 [Abstract] [Full Text] [Related]
5. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis. Roomans GM. Am J Respir Med; 2003 Nov; 2(5):413-31. PubMed ID: 14719993 [Abstract] [Full Text] [Related]
11. Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis. Gianotti A, Melani R, Caci E, Sondo E, Ravazzolo R, Galietta LJ, Zegarra-Moran O. Am J Respir Cell Mol Biol; 2013 Sep; 49(3):445-52. PubMed ID: 23600628 [Abstract] [Full Text] [Related]
13. Mathematical model reveals role of nucleotide signaling in airway surface liquid homeostasis and its dysregulation in cystic fibrosis. Sandefur CI, Boucher RC, Elston TC. Proc Natl Acad Sci U S A; 2017 Aug 29; 114(35):E7272-E7281. PubMed ID: 28808008 [Abstract] [Full Text] [Related]
19. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis. Shei RJ, Peabody JE, Kaza N, Rowe SM. Curr Opin Pharmacol; 2018 Dec 29; 43():152-165. PubMed ID: 30340955 [Abstract] [Full Text] [Related]
20. [CFTR and transepithelial ionic transport abnormalities in cystic fibrosis]. Becq F. Arch Pediatr; 2003 Sep 29; 10 Suppl 2():325s-332s. PubMed ID: 14671929 [Abstract] [Full Text] [Related] Page: [Next] [New Search]